Trial intelligence / Profile preview

Impact of BPC-157 on Recovery From Rotator Cuff Repair Surgery

NCT07803250Phase 1Not yet recruiting

Sponsor
University of Arkansas
Start
Jan 2027
Primary completion
Aug 2027
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of bpc-157 in rotator cuff tear (2 arms), sponsored by University of Arkansas. Primary endpoint: Shoulder Strength at 21 weeks. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

bpc-157
03

Conditions

rotator cuff tear

Beyond the preview

Go deeper on NCT07803250.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07803250.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call